Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Genotype 4 Infection”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02247401
What this trial is testing

Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt

Who this might be right for
HCVHepatitis C InfectionGenotype 4
AbbVie 160
Testing effectiveness (Phase 2)Study completedNCT02457611
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection

Who this might be right for
Hepatitis C Infection With HIV Co-Infection
Gilead Sciences 26
Large-scale testing (Phase 3)Study completedNCT00158522
What this trial is testing

Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)

Who this might be right for
Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 31
Large-scale testing (Phase 3)Study completedNCT01197157
What this trial is testing

Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients

Who this might be right for
Hepatitis C
National Liver Institute, Egypt 200
Not applicableStudy completedNCT03303599
What this trial is testing

Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6

Who this might be right for
Hepatitis C
AbbVie 2,118
Testing effectiveness (Phase 2)Study completedNCT00901524
What this trial is testing

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV

Who this might be right for
Hepatitis
ANRS, Emerging Infectious Diseases 58
Post-approval studies (Phase 4)Study completedNCT03111108
What this trial is testing

Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-096)

Who this might be right for
Hepatitis C Virus (HCV) Infection
Merck Sharp & Dohme LLC 117
Large-scale testing (Phase 3)Study completedNCT02600325
What this trial is testing

Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV

Who this might be right for
Acute Hepatitis CHuman Immunodeficiency VirusHepatitis C
Erasmus Medical Center 80
Testing effectiveness (Phase 2)Ended earlyNCT02759315
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 160
Post-approval studies (Phase 4)UnknownNCT02691728
What this trial is testing

Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 and 4 HCV Infection With Autoimmune Disease

Who this might be right for
Chronic Hepatitis C
Peter J. Ruane, M.D., Inc. 40
Large-scale testing (Phase 3)Study completedNCT02358044
What this trial is testing

Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection (MK-5172-077)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 257
Testing effectiveness (Phase 2)Study completedNCT00812331
What this trial is testing

Assess the Anti-viral Activity, Safety, Tolerability and Pharmacokinetics of TMC435350 in Participants Infected With Hepatitis C-Virus (HCV)

Who this might be right for
Hepatitis C
Tibotec Pharmaceuticals, Ireland 37
Large-scale testing (Phase 3)Study completedNCT02707952
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C VirusHepatitis C Virus
AbbVie 295
Not applicableUnknownNCT04662138
What this trial is testing

Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus Relapse

Who this might be right for
Hepatitis CRelapseAntivirals
Alexandria University 100
Testing effectiveness (Phase 2)Study completedNCT02253550
What this trial is testing

Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C
Peter J. Ruane, M.D. 30
Early research (Phase 1)Study completedNCT01740791
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 103
Large-scale testing (Phase 3)Ended earlyNCT00662220
What this trial is testing

High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 110
Not applicableUnknownNCT01758939
What this trial is testing

Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients

Who this might be right for
Hepatitis C, Chronic
Cairo University 100,000
Testing effectiveness (Phase 2)Study completedNCT04387539
What this trial is testing

ٍٍSofosbuvir/Simeprevir/Daclatasvir/Ribavirin and HCV Genotype 4-infected Egyptian Experienced Participants

Who this might be right for
Chronic Hepatitis C Virus Infection
Beni-Suef University 94
Testing effectiveness (Phase 2)Study completedNCT01685203
What this trial is testing

Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott) 316
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation